Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for P50458

Entry ID Method Resolution Chain Position Source
AF-P50458-F1 Predicted AlphaFoldDB

267 variants for P50458

Variant ID(s) Position Change Description Diseaes Association Provenance
CA374860669
rs1179688706
7 S>L No ClinGen
gnomAD
CA374860715
rs1425252450
13 G>E No ClinGen
gnomAD
rs968124826
CA199653136
16 D>Y No ClinGen
Ensembl
rs755380207
CA5233756
17 E>K No ClinGen
ExAC
gnomAD
rs1262723657
CA374860752
18 M>I No ClinGen
TOPMed
CA5233757
rs767900210
18 M>T No ClinGen
ExAC
TOPMed
gnomAD
CA374860756
rs1447163494
19 D>G No ClinGen
gnomAD
rs752934468
CA5233758
19 D>N No ClinGen
ExAC
gnomAD
TCGA novel 20 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA374860763
rs1324987801
20 R>H No ClinGen
gnomAD
CA374860765
rs1324987801
20 R>L No ClinGen
gnomAD
CA374860766
rs1407632691
21 R>G No ClinGen
gnomAD
CA5233759
rs756249258
22 A>T No ClinGen
ExAC
gnomAD
CA374860803
rs777932165
26 A>S No ClinGen
ExAC
TOPMed
gnomAD
CA5233760
rs777932165
26 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs1042853209
CA199653149
26 A>V No ClinGen
TOPMed
gnomAD
CA374860807
rs1218118920
27 P>A No ClinGen
gnomAD
rs1211321482
CA374860819
29 I>V No ClinGen
TOPMed
CA374860838
rs1486620338
31 S>F No ClinGen
TOPMed
rs1256675627
CA374860839
32 A>S No ClinGen
TOPMed
gnomAD
CA374860853
rs1320625646
34 D>H No ClinGen
gnomAD
CA374860860
rs1267088691
35 R>S No ClinGen
gnomAD
CA374860866
rs1200510281
36 G>S No ClinGen
TOPMed
gnomAD
CA374860874
rs1588343930
37 D>A No ClinGen
Ensembl
rs368708873
CA374860872
37 D>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs368708873
CA5233761
37 D>Y No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5233762
rs757223404
38 T>A No ClinGen
ExAC
gnomAD
CA374860884
rs1360827094
39 E>K No ClinGen
TOPMed
rs1298032374
CA374860896
40 T>M No ClinGen
TOPMed
rs758295305
CA5233782
41 T>A No ClinGen
ExAC
gnomAD
rs752440722
CA5233784
42 M>L No ClinGen
ExAC
gnomAD
rs752440722
CA5233783
42 M>V No ClinGen
ExAC
gnomAD
rs532587351
CA199653789
43 P>L No ClinGen
ExAC
gnomAD
rs532587351
CA5233785
43 P>R No ClinGen
ExAC
gnomAD
CA374860933
rs780690752
45 I>F No ClinGen
ExAC
TOPMed
gnomAD
rs780690752
CA5233786
45 I>L No ClinGen
ExAC
TOPMed
gnomAD
rs780690752
CA374860932
45 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA374860941
rs1287779088
46 S>N No ClinGen
gnomAD
CA374860943
rs1287779088
46 S>T No ClinGen
gnomAD
rs533198310
CA374860963
49 R>C No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA5233789
rs533198310
49 R>G No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 49 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA374860965
rs1564548216
49 R>P No ClinGen
Ensembl
rs533198310
CA5233788
49 R>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs113895098
CA199653804
50 A>T No ClinGen
TOPMed
gnomAD
rs1188230279
CA374860972
51 A>T No ClinGen
gnomAD
CA374860993
rs1422020678
54 A>S No ClinGen
TOPMed
CA374860999
rs1362713822
55 G>S No ClinGen
gnomAD
CA374861012
rs1370844767
57 G>R No ClinGen
gnomAD
CA374861011
rs1370844767
57 G>W No ClinGen
gnomAD
TCGA novel 58 G>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1158464183
CA374861017
58 G>S No ClinGen
TOPMed
rs370570070
CA5233795
59 K>R No ClinGen
ESP
ExAC
gnomAD
rs1415274703
CA374861040
61 S>L Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs1427452128
CA374861061
64 Y>C No ClinGen
TOPMed
TCGA novel 69 V>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA374861099
rs1588344843
70 D>G No ClinGen
Ensembl
CA374861122
rs1376601922
73 W>* No ClinGen
gnomAD
rs867375573
CA199653837
76 R>C No ClinGen
Ensembl
rs1353984800
CA374861167
79 K>R No ClinGen
gnomAD
CA374861189
rs1231821859
82 E>Q No ClinGen
gnomAD
CA374861202
rs1253724724
83 C>* No ClinGen
gnomAD
CA374861285
rs1210127636
95 S>T No ClinGen
TOPMed
rs913850378
CA199653866
100 I>S No ClinGen
TOPMed
CA374861362
rs1419909165
104 E>G No ClinGen
gnomAD
rs1564548291
CA374861394
107 Y>N No ClinGen
Ensembl
rs901719061
CA199654296
109 R>C No ClinGen
Ensembl
rs1476903416
CA374861901
109 R>L No ClinGen
gnomAD
CA5233837
rs766398944
116 A>G No ClinGen
ExAC
gnomAD
CA374861981
rs1469059585
117 R>G No ClinGen
TOPMed
CA374862176
rs1297242646
130 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs943713949
CA374862185
131 A>P No ClinGen
TOPMed
gnomAD
CA199654321
rs943713949
131 A>S No ClinGen
TOPMed
gnomAD
TCGA novel 131 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA199654326
rs538436147
131 A>V No ClinGen
Ensembl
rs755961022
CA5233842
COSM3699265
132 R>Q large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
TCGA novel 132 R>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs763890377
CA5233843
134 L>F No ClinGen
ExAC
TOPMed
gnomAD
rs753512234
CA5233844
139 N>H No ClinGen
ExAC
gnomAD
rs756897654
CA5233845
139 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA199654348
rs549494441
142 T>M No ClinGen
1000Genomes
gnomAD
TCGA novel
CA5233849
rs781712063
148 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
ClinGen
ExAC
TOPMed
gnomAD
rs1207316439
CA374862385
149 M>L No ClinGen
TOPMed
CA5233850
rs748558803
149 M>T No ClinGen
ExAC
gnomAD
CA374862419
rs1588345478
151 T>I No ClinGen
Ensembl
CA374862504
rs1228926589
157 G>C No ClinGen
TOPMed
CA374862506
rs1180683785
157 G>D No ClinGen
gnomAD
rs1228926589
CA374862492
157 G>S No ClinGen
TOPMed
CA5233852
rs773524246
159 K>E No ClinGen
ExAC
gnomAD
CA5233853
rs749532336
161 S>N No ClinGen
ExAC
gnomAD
CA374862627
rs1420916571
166 R>C No ClinGen
gnomAD
rs1318426104
CA374862631
166 R>H No ClinGen
gnomAD
rs375687666
CA5233856
169 F>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs368805518
CA5233858
174 Q>L No ClinGen
ESP
ExAC
gnomAD
rs1292248579
CA374862773
179 A>S No ClinGen
gnomAD
rs764015032
CA5233860
180 H>Y Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs753641074
CA5233861
182 N>K No ClinGen
ExAC
gnomAD
CA5233862
rs761390346
184 A>D No ClinGen
ExAC
TOPMed
gnomAD
rs757898602
CA5233866
185 D>E No ClinGen
ExAC
TOPMed
gnomAD
CA5233864
rs567713261
185 D>N No ClinGen
1000Genomes
ExAC
gnomAD
CA5233867
rs753230621
186 V>L No ClinGen
ExAC
gnomAD
TCGA novel 187 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5233872
rs778123020
190 A>S No ClinGen
ExAC
gnomAD
rs771124607
CA5233874
191 A>S No ClinGen
ExAC
gnomAD
CA5233875
rs779183982
191 A>V No ClinGen
ExAC
gnomAD
CA5233876
rs745984084
192 A>E No ClinGen
ExAC
TOPMed
gnomAD
CA374862932
rs1178079328
193 A>V No ClinGen
TOPMed
gnomAD
rs775673483
CA5233879
194 A>T No ClinGen
ExAC
gnomAD
rs1378909150
CA374862947
195 A>T No ClinGen
TOPMed
gnomAD
rs961352521
CA199654443
195 A>V No ClinGen
gnomAD
rs1372315817
CA374862959
196 A>T No ClinGen
TOPMed
rs866465572
CA199654450
198 S>R No ClinGen
Ensembl
rs776576461
CA5233882
199 A>S No ClinGen
ExAC
gnomAD
rs1162316630
CA374863015
201 L>M No ClinGen
TOPMed
CA5233886
rs762469815
202 G>S No ClinGen
ExAC
gnomAD
rs765895014
CA5233887
203 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs756617799
CA5233889
206 A>S No ClinGen
ExAC
gnomAD
CA374863070
rs1465025643
207 N>D No ClinGen
gnomAD
rs754213670
CA5233891
208 P>L No ClinGen
ExAC
gnomAD
rs1402161306
CA374863084
208 P>S No ClinGen
gnomAD
rs1200849534
CA374863105
210 G>D No ClinGen
TOPMed
CA5233893
rs779045579
210 G>S No ClinGen
ExAC
gnomAD
rs1285259902
CA374863129
212 P>L No ClinGen
TOPMed
gnomAD
CA374863137
rs1346306936
213 Y>C No ClinGen
gnomAD
rs1218534126
CA374863149
214 Y>C No ClinGen
gnomAD
rs1256772758
CA374863156
215 N>H No ClinGen
gnomAD
CA374863163
rs1341845501
215 N>S No ClinGen
gnomAD
CA5233895
rs189601606
217 V>M No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1158234741
CA374863198
218 G>D No ClinGen
gnomAD
rs1221785548
CA374863211
220 V>M No ClinGen
TOPMed
CA374863275
rs1268970668
225 P>L No ClinGen
gnomAD
rs1054695991
CA199654503
226 R>K No ClinGen
Ensembl
rs1191389072
CA374863291
227 K>R No ClinGen
gnomAD
CA374863300
rs1374754197
228 R>C No ClinGen
gnomAD
rs1475581575
CA374863303
228 R>P No ClinGen
gnomAD
CA374863297
rs1374754197
228 R>S No ClinGen
gnomAD
rs747022702
CA5233897
229 K>T No ClinGen
ExAC
TOPMed
gnomAD
rs768784762
CA5233898
230 S>I No ClinGen
ExAC
gnomAD
rs776604677
CA5233899
231 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA199654518
rs571577241
231 P>S No ClinGen
1000Genomes
TCGA novel 232 G>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA374863350
rs1366254572
233 P>A No ClinGen
gnomAD
rs754466751
CA199654526
234 G>C No ClinGen
TOPMed
gnomAD
CA374863369
rs1328709712
235 A>V No ClinGen
gnomAD
rs772832117
CA5233902
236 D>Y No ClinGen
ExAC
TOPMed
gnomAD
rs901604624
CA199654534
238 A>S No ClinGen
gnomAD
rs901604624
CA374863391
238 A>T No ClinGen
gnomAD
rs995859788
CA199654538
238 A>V No ClinGen
TOPMed
gnomAD
CA374863407
rs1177515868
239 A>G No ClinGen
TOPMed
CA374863403
rs1363594530
239 A>S No ClinGen
TOPMed
rs1481720994
CA374863418
240 Y>C No ClinGen
TOPMed
rs1050701333
CA199654541
241 N>K No ClinGen
TOPMed
CA374863431
rs1292114193
241 N>S No ClinGen
TOPMed
gnomAD
rs762679057
CA5233903
242 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs887606540
CA199654548
242 A>V No ClinGen
Ensembl
rs560527359
CA5233930
243 A>G No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA374864347
rs560527359
243 A>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1588348683
CA374864363
245 S>R No ClinGen
Ensembl
rs751859167
CA5233933
246 C>S No ClinGen
ExAC
gnomAD
CA374864372
rs1316266589
247 N>H No ClinGen
Ensembl
CA374864379
rs755198475
247 N>K No ClinGen
ExAC
gnomAD
TCGA novel 248 E>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs879062209
CA199657918
248 E>G No ClinGen
Ensembl
rs1303464139
CA374864380
248 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA374864393
rs1456308379
CA374864394
249 N>K No ClinGen
gnomAD
TCGA novel 250 D>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA374864395
rs1306991006
250 D>N No ClinGen
TOPMed
CA199657923
rs973270362
251 A>S No ClinGen
TOPMed
gnomAD
CA374864405
rs973270362
251 A>T No ClinGen
TOPMed
gnomAD
TCGA novel 252 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs781342669
CA5233935
252 E>Q No ClinGen
ExAC
TOPMed
gnomAD
rs748107648
CA5233936
253 H>L No ClinGen
ExAC
TOPMed
gnomAD
rs1471239345
CA374864440
254 L>V No ClinGen
gnomAD
rs1177834475
CA374864450
255 D>N No ClinGen
gnomAD
rs777556738
CA5233938
256 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs777556738
CA199657937
256 R>G No ClinGen
ExAC
TOPMed
gnomAD
rs749130254
CA199657952
COSM1459940
256 R>H large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs749130254
CA5233939
256 R>P No ClinGen
ExAC
TOPMed
gnomAD
CA5233941
rs770682530
257 D>A No ClinGen
ExAC
gnomAD
rs979762975
CA199657970
258 Q>K No ClinGen
Ensembl
CA5233942
rs140229756
259 P>Q No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs771568317
CA5233944
261 P>L No ClinGen
ExAC
TOPMed
gnomAD
rs771568317
CA374864522
261 P>R No ClinGen
ExAC
TOPMed
gnomAD
rs760101514
CA5233946
266 T>I No ClinGen
ExAC
gnomAD
CA5233949
rs763510121
269 M>I No ClinGen
ExAC
gnomAD
CA5233951
rs751912499
286 A>T No ClinGen
ExAC
gnomAD
rs1274615285
CA374865310
288 N>D No ClinGen
gnomAD
CA199658014
rs767627020
292 D>E No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 297 K>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA374865444
rs1355543482
298 Q>H No ClinGen
gnomAD
CA5233954
rs752878477
300 A>P No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 301 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA374865509
rs1405055112
304 G>D No ClinGen
gnomAD
rs779800895
CA5233981
317 A>T No ClinGen
ExAC
gnomAD
rs747654439
CA5233985
321 F>L No ClinGen
ExAC
gnomAD
rs1449784215
CA374866161
323 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA374866164
rs1338436392
323 R>L No ClinGen
gnomAD
CA374866188
rs1453619025
327 R>Q No ClinGen
gnomAD
CA5233986
rs771622276
329 E>G No ClinGen
ExAC
gnomAD
rs774975929
CA5233987
330 N>K No ClinGen
ExAC
gnomAD
rs1371216473
CA374866209
330 N>T No ClinGen
gnomAD
CA5233989
rs772345058
332 G>A No ClinGen
ExAC
gnomAD
rs1462081942
CA374866226
333 V>E No ClinGen
gnomAD
rs151109428
CA5233990
333 V>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA374866236
rs1564553864
334 D>E No ClinGen
Ensembl
rs764241410
CA5233992
336 S>L No ClinGen
ExAC
gnomAD
TCGA novel 336 S>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs762693228
CA374866267
339 A>E No ClinGen
ExAC
gnomAD
rs1177285065
CA374866264
339 A>T No ClinGen
gnomAD
rs762693228
CA5233994
339 A>V No ClinGen
ExAC
gnomAD
CA374866269
rs1195957735
COSM752738
340 A>T lung Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs1178554096
CA374866274
340 A>V No ClinGen
TOPMed
gnomAD
CA374866282
rs1564553894
342 Q>* No ClinGen
Ensembl
rs1328391312
CA374866286
342 Q>H No ClinGen
gnomAD
rs1325983747
CA374866298
344 G>E No ClinGen
TOPMed
rs1444394983
CA374866303
345 T>M No ClinGen
gnomAD
rs751314499
CA5233999
346 P>S No ClinGen
ExAC
gnomAD
CA5234000
rs751314499
346 P>T No ClinGen
ExAC
gnomAD
CA199663328
rs369099431
347 S>L No ClinGen
ESP
TOPMed
gnomAD
rs780990221
COSM752737
CA5234001
348 G>V lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA374866321
rs1166683585
349 P>A No ClinGen
TOPMed
rs1324665644
CA374866323
349 P>L No ClinGen
TOPMed
gnomAD
rs1324665644
CA374866325
349 P>R No ClinGen
TOPMed
gnomAD
TCGA novel 350 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA374866345
rs1267522986
352 E>D No ClinGen
gnomAD
rs777369931
CA5234006
353 L>F No ClinGen
ExAC
gnomAD
CA5234007
rs746392772
355 N>D No ClinGen
ExAC
gnomAD
CA374866363
rs1429949286
355 N>K No ClinGen
TOPMed
gnomAD
rs893877314
CA199663365
355 N>S No ClinGen
Ensembl
CA5234008
rs772563433
356 A>T No ClinGen
ExAC
gnomAD
CA5234009
COSM384154
rs775730128
357 S>L lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA374866400
rs1203399461
359 S>R No ClinGen
TOPMed
CA374866492
rs1329850991
365 T>A No ClinGen
gnomAD
CA5234012
rs776799769
365 T>I No ClinGen
ExAC
gnomAD
CA374866507
rs1403212401
366 T>I No ClinGen
gnomAD
CA374866518
rs1305418533
367 L>R No ClinGen
gnomAD
rs761926920
CA5234013
368 T>K No ClinGen
ExAC
gnomAD
rs765319512
CA5234014
369 D>G No ClinGen
ExAC
gnomAD
rs551135959
CA5234015
371 T>A No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs762815287
CA5234016
371 T>I No ClinGen
ExAC
gnomAD
rs762815287
CA374866568
371 T>N No ClinGen
ExAC
gnomAD
CA374866564
rs551135959
371 T>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1448778106
CA374866615
375 L>V No ClinGen
gnomAD
CA374866639
rs1489617052
377 T>A No ClinGen
TOPMed
gnomAD
CA5234018
rs569272766
377 T>I No ClinGen
1000Genomes
ExAC
gnomAD
rs1489617052
CA374866635
377 T>P No ClinGen
TOPMed
gnomAD
TCGA novel 378 V>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5234020
rs533321722
379 T>A Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
gnomAD
CA5234021
rs752421293
379 T>M No ClinGen
ExAC
gnomAD
rs533321722
CA5234019
379 T>S No ClinGen
1000Genomes
ExAC
gnomAD
CA374866684
rs1475631589
381 V>I No ClinGen
gnomAD
rs1169421382
CA374866715
383 T>S No ClinGen
gnomAD
rs1352151504
CA374866733
385 V>L No ClinGen
TOPMed
CA374866758
rs1305979331
387 G>D No ClinGen
TOPMed
CA5234023
rs777152260
387 G>R No ClinGen
ExAC
gnomAD
CA374866773
rs1165531483
388 N>K No ClinGen
gnomAD
CA374866785
rs1366341343
389 L>R No ClinGen
gnomAD
TCGA novel 394 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA374866848
rs1316908197
394 P>T No ClinGen
gnomAD
rs1455981403
CA374866890
397 P>T No ClinGen
TOPMed
rs1588354517
CA374866913
398 S>L No ClinGen
Ensembl
CA5234028
rs768983413
399 Q>R No ClinGen
ExAC
gnomAD
rs781483915
CA5234029
400 T>A No ClinGen
ExAC
gnomAD
CA199663472
rs998449551
400 T>M No ClinGen
TOPMed
rs1203260098
CA374866944
401 T>A No ClinGen
gnomAD
rs769950167
CA5234031
404 N>S No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 406 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA

No associated diseases with P50458

9 regional properties for P50458

Type Name Position InterPro Accession
repeat Leucine-rich repeat 86 - 152 IPR001611-1
repeat Leucine-rich repeat 153 - 211 IPR001611-2
repeat Leucine-rich repeat 222 - 280 IPR001611-3
repeat Leucine-rich repeat, typical subtype 105 - 127 IPR003591-1
repeat Leucine-rich repeat, typical subtype 128 - 151 IPR003591-2
repeat Leucine-rich repeat, typical subtype 175 - 197 IPR003591-3
repeat Leucine-rich repeat, typical subtype 198 - 220 IPR003591-4
repeat Leucine-rich repeat, typical subtype 221 - 243 IPR003591-5
repeat Leucine-rich repeat, typical subtype 244 - 267 IPR003591-6

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
chromatin The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

6 GO annotations of molecular function

Name Definition
chromatin binding Binding to chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase.
DNA-binding transcription activator activity, RNA polymerase II-specific A DNA-binding transcription factor activity that activates or increases transcription of specific gene sets transcribed by RNA polymerase II.
DNA-binding transcription factor activity, RNA polymerase II-specific A DNA-binding transcription factor activity that modulates the transcription of specific gene sets transcribed by RNA polymerase II.
metal ion binding Binding to a metal ion.
RNA polymerase II cis-regulatory region sequence-specific DNA binding Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II.
RNA polymerase II transcription regulatory region sequence-specific DNA binding Binding to a specific sequence of DNA that is part of a regulatory region that controls the transcription of a gene or cistron by RNA polymerase II.

18 GO annotations of biological process

Name Definition
axon extension Long distance growth of a single axon process involved in cellular development.
axon guidance The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.
cerebral cortex development The progression of the cerebral cortex over time from its initial formation until its mature state. The cerebral cortex is the outer layered region of the telencephalon.
dorsal/ventral pattern formation The regionalization process in which the areas along the dorsal/ventral axis are established that will lead to differences in cell differentiation. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism.
hair follicle development The process whose specific outcome is the progression of the hair follicle over time, from its formation to the mature structure. A hair follicle is a tube-like opening in the epidermis where the hair shaft develops and into which the sebaceous glands open.
maintenance of epithelial cell apical/basal polarity The maintenance of the apicobasal polarity of an epithelial cell.
mesoderm development The process whose specific outcome is the progression of the mesoderm over time, from its formation to the mature structure. The mesoderm is the middle germ layer that develops into muscle, bone, cartilage, blood and connective tissue.
negative regulation of gene expression, epigenetic An epigenetic process that silences gene expression at specific genomic regions through chromatin remodelling either by modifying higher order chromatin fiber structure, nucleosomal histones, or the DNA.
negative regulation of neurogenesis Any process that stops, prevents, or reduces the frequency, rate or extent of neurogenesis, the generation of cells within the nervous system.
negative regulation of transcription regulatory region DNA binding Any process that stops, prevents or reduces the frequency, rate or extent of transcription regulatory region DNA binding.
neural tube closure The last step in the formation of the neural tube, where the paired neural folds are brought together and fuse at the dorsal midline.
neuron differentiation The process in which a relatively unspecialized cell acquires specialized features of a neuron.
olfactory bulb development The progression of the olfactory bulb over time from its initial formation until its mature state. The olfactory bulb coordinates neuronal signaling involved in the perception of smell. It receives input from the sensory neurons and outputs to the olfactory cortex.
positive regulation of DNA-templated transcription Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
positive regulation of neural precursor cell proliferation Any process that activates or increases the frequency, rate or extent of neural precursor cell proliferation.
regulation of transcription by RNA polymerase II Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
retina development in camera-type eye The process whose specific outcome is the progression of the retina over time, from its formation to the mature structure. The retina is the innermost layer or coating at the back of the eyeball, which is sensitive to light and in which the optic nerve terminates.
telencephalon regionalization The regionalization process that creates areas within the forebrain that will direct the behavior of cell migration in differentiation as the telencephalon develops.

21 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
A0JNI8 LHX9 LIM/homeobox protein Lhx9 Bos taurus (Bovine) PR
Q90881 LHX9 LIM/homeobox protein Lhx9 Gallus gallus (Chicken) PR
F1NEA7 DMBX1 Diencephalon/mesencephalon homeobox protein 1 Gallus gallus (Chicken) PR
Q90963 PRRX2 Paired mesoderm homeobox protein 2 Gallus gallus (Chicken) PR
Q8IRC7 Awh LIM/homeobox protein Awh Drosophila melanogaster (Fruit fly) PR
Q8NHV9 RHOXF1 Rhox homeobox family member 1 Homo sapiens (Human) PR
O95076 ALX3 Homeobox protein aristaless-like 3 Homo sapiens (Human) PR
Q9BQY4 RHOXF2 Rhox homeobox family member 2 Homo sapiens (Human) PR
Q99811 PRRX2 Paired mesoderm homeobox protein 2 Homo sapiens (Human) PR
O15266 SHOX Short stature homeobox protein Homo sapiens (Human) PR
Q9NQ69 LHX9 LIM/homeobox protein Lhx9 Homo sapiens (Human) PR
P63013 Prrx1 Paired mesoderm homeobox protein 1 Mus musculus (Mouse) PR
Q8VIH1 Nobox Homeobox protein NOBOX Mus musculus (Mouse) PR
Q06348 Prrx2 Paired mesoderm homeobox protein 2 Mus musculus (Mouse) PR
O88933 Esx1 Extraembryonic, spermatogenesis, homeobox 1 (Homeobox protein SPX1) (Homeodomain protein EPX) Mus musculus (Mouse) EV
Q9WUH2 Lhx9 LIM/homeobox protein Lhx9 Mus musculus (Mouse) PR
Q80W90 Lhx9 LIM/homeobox protein Lhx9 Rattus norvegicus (Rat) PR
P36198 Lhx2 LIM/homeobox protein Lhx2 Rattus norvegicus (Rat) PR
Q28G02 siamois Homeobox protein siamois Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
Q566X8 dmbx1b Diencephalon/mesencephalon homeobox protein 1-B Danio rerio (Zebrafish) (Brachydanio rerio) PR
Q1LWV4 lhx9 LIM/homeobox protein Lhx9 Danio rerio (Zebrafish) (Brachydanio rerio) PR
10 20 30 40 50 60
MLFHSLSGPE VHGVIDEMDR RAKSEAPAIS SAIDRGDTET TMPSISSDRA ALCAGCGGKI
70 80 90 100 110 120
SDRYYLLAVD KQWHMRCLKC CECKLNLESE LTCFSKDGSI YCKEDYYRRF SVQRCARCHL
130 140 150 160 170 180
GISASEMVMR ARDLVYHLNC FTCTTCNKML TTGDHFGMKD SLVYCRLHFE ALLQGEYPAH
190 200 210 220 230 240
FNHADVAAAA AAAAAAKSAG LGAAGANPLG LPYYNGVGTV QKGRPRKRKS PGPGADLAAY
250 260 270 280 290 300
NAALSCNEND AEHLDRDQPY PSSQKTKRMR TSFKHHQLRT MKSYFAINHN PDAKDLKQLA
310 320 330 340 350 360
QKTGLTKRVL QVWFQNARAK FRRNLLRQEN TGVDKSTDAA LQTGTPSGPA SELSNASLSP
370 380 390 400
SSTPTTLTDL TSPTLPTVTS VLTSVPGNLE GHEPHSPSQT TLTNLF